Saavedra, Jacqueline .

HRN: 19-96-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
12/30/2024
01/06/2025
PO
2.5 Ml
Q8h
UTI, PCAP B
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: